Artificial Intelligence Applications in Cardio-Oncology: A Comprehensive Review.
Avirup Guha1,2, Viraj Shah3,4, Tarek Nahle3,4
1Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA. aguha@augusta.edu.
Artificial intelligence (AI) enhances cardio-oncology by improving diagnosis and risk prediction for cardiovascular complications in cancer patients. Addressing data and ethical challenges is key for AI
Area of Science:
- Cardio-oncology
- Artificial Intelligence
- Biomarker Discovery
Background:
- Cardiovascular complications are a significant concern for cancer patients.
- Early detection and management of cardiotoxicity are crucial for improving patient outcomes.
Purpose of the Study:
- To review the role and applications of AI in cardio-oncology.
- To explore AI's impact on diagnosis, prognosis, risk stratification, and management of cardiovascular issues in cancer patients.
- To highlight advancements and challenges in AI for cardio-oncology.
Main Methods:
- Review of current literature on AI applications in cardio-oncology.
- Analysis of AI's use with imaging, electronic health records (EHRs), electrocardiograms (ECG), and multi-omics data.
- Discussion of challenges such as data heterogeneity and ethical concerns.
Main Results:
- AI leverages diverse data sources (imaging, EHRs, ECG, multi-omics) for early cardiotoxicity detection and risk prediction.
- Novel AI-ECG models and imaging techniques enhance diagnostic accuracy.
- Multi-omics analysis aids in identifying biomarkers for personalized cancer patient treatment.
- AI shows significant potential in early detection and intervention strategies.
Conclusions:
- AI significantly advances cardio-oncology by improving early detection and intervention for cardiovascular complications.
- Addressing data heterogeneity, transparency, and ethical concerns is vital for AI adoption.
- Future research should focus on AI's clinical impact and ethical considerations to enhance patient care.
More Related Videos
07:46Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
